Search results
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 17 hours ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...
AbbVie inks immune disorder drug licensing deal with China's FutureGen
Reuters via Yahoo News· 14 hours agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of...
Moderna's Combo Flu/Covid Shot Topped Rivals From Sanofi, GSK
Investor's Business Daily· 4 days agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Zacks via Yahoo Finance· 18 hours agoProthena’s Alzheimer’s candidate is PRX012, a next-generation subcutaneous antibody targeting a key...
The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A Record
Investor's Business Daily· 1 day agoBiomarkers of FHSD also declined by an average of 25% or greater. The results "provide further...
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
Yahoo Finance· 3 days agoAn FDA panel voted 11-0 Monday to recommend the use of Eli Lilly's (LLY) early-stage Alzheimer's...
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 2 days agoThe meeting on Monday gives companies like Biogen, Eisai, and Lilly some hope of getting back on...
AbbVie joins TL1A race via $150M upfront deal with China's FutureGen
FierceBiotech· 14 hours agoAbbVie has become the latest Big Pharma to jump on the anti-TL1A train, paying China’s FutureGen Biopharmaceutical $150 million upfront for a preclinical inflammatory bowel disease (IBD) candidate ...
Understanding the immune system's 'big eater': New insights into macrophage behavior in cancer...
Medical Xpress· 7 days agoThe study, titled "Antibody surface mobility amplifies Fc gammaR signaling via Arp2/3 during phagocytosis," was published in the Biophysical Journal.
Acticor Biotech Fab Fragment Development & Manufacturing
BioresearchOnline· 1 day agoGlenzocimab (ACT017) is a humanized Fab fragment of a monoclonalantibody, targeting platelet...